Processed version of the MaxQuant phosphosite table of the experiments with tirabrutinib-treated U-2932 cells.

For all confidently localized phosphorylation sites (localization probability ≥0.75%), SILAC ratios of individual replicate experiments are reported. Class 1 site ratios that were reproducibly identified are indicated and further marked as regulated in case of consistent up- or downregulation. The tirabrutinib/control phosphosite ratios from Experiment 2 correspond to the normalized and inverted H/L ratio due to the introduced label switch compared to Experiment 1. (XLSX)针对所有经可靠定位的磷酸化位点（定位概率≥0.75%），本数据集收录了单次重复实验的SILAC（细胞培养稳定同位素标记）比值。经可重复鉴定的1类磷酸化位点比值将予以标注；若该位点存在一致的上调或下调趋势，则进一步标记为「调控位点」。相较于实验1，实验2引入了标记转换，因此实验2中替拉布鲁替尼（Tirabrutinib）/对照组的磷酸化位点比值对应经归一化处理并反转后的H/L比值。(XLSX)